Organic electroluminescence device, preparation method thereof and display apparatus
US-11508927-B2 · Nov 22, 2022 · US
US12402525B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12402525-B2 |
| Application number | US-202117452318-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2021 |
| Priority date | Oct 29, 2020 |
| Publication date | Aug 26, 2025 |
| Grant date | Aug 26, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a heterocyclic compound represented by Formula 1, a light-emitting device including the same, and an electronic apparatus including the light-emitting device. The light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and the heterocyclic compound represented by Formula 1.
Opening claim text (preview).
What is claimed is: 1. A heterocyclic compound represented by Formula 1: wherein, in Formula 1, EW 11 is —CN, d1 is 0 or 1, wherein EW 1 in Formula 1 is an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyridazine group, a pyrimidine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a benzoisoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a benzoquinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, a benzoisothiazole group, a benzoxazole group, a benzoisoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, an azacarbazole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzosilole group, an acridine group, or a pyridopyrazine group, or T 1 is a group represented by Formula 2, and b1 is an integer from 1 to 5, wherein, in Formula 2, X 1 is O or S, L 1 is a single bond, a C 4 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a1 is an integer from 0 to 5, and Ar 1 and Ar 2 are each independently a π electron-rich C 3 -C 60 cyclic group unsubstituted or substituted with at least one R 10a , and wherein, in Formulae 1 and 2, R 1 and R 2 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), or —C(═O)(Q 1 ), c1 in Formula 1 is an integer from 0 to 10, c2 in Formula 2 is an integer from 0 to 7, and R 10a is: deuterium (-D), —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 7 -C 60 arylalkyl group, a C 2 -C 60 heteroarylalkyl group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof; a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -Coo aryloxy group, a C 6 -C 60 arylthio group, a C 7 -C 60 arylalkyl group, a C 2 -C 60 heteroarylalkyl group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), wherein Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof, * in Formula 2 indicates a binding site to EW 1 in Formula 1, and wherein when d1 is 0, either (i) b1 is an integer from 2 to 5, or (ii) c1 in Formula 1 is an integer from 2 to 10 and at least one R 1 is a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a and at least one other R 1 is a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a . 2. The heterocyclic compound of claim 1 , wherein the heterocyclic compound is represented by Formula 1(a) or 1(b): wherein, in Formulae 1(a) and 1(b), X 11 is N or C(R 11 ), X 12 is N or C(R 12 ), X 13 is N or C(R 13 ), at least one selected from X 11 to X 13 is N or C(CN), R 11 to R 15 are the same as described in connection with R 1 , and T 11 and T 12 are the same as described in connection with T 1 . 3. A heterocyclic compound represented by Formula 1(a) or 1(b): wherein, in Formulae 1(a) and 1(b), X 11 is N or C(R 11 ), X 12 is N or C(R 12 ), X 13 is N or C(R 13 ), T 11 and T 12 are each a group represented by Formula 2, and wherein, in Formula 2, X 1 is O or S, L 1 is a single bond, a C 4 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a1 is an integer from 0 to 5, and Ar 1 and Ar 2 are each independently a Ir electron-rich C 3 -C 60 cyclic group unsubstituted or substituted with at least one R 10a , and wherein, in Formulae 1(a), 1(b), and 2, R 2 and R 11 to R 15 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), or —C(═O)(Q 1 ), wherein at least one of R 11 to R 15 is a C 3 -C 60 carboxylic group unsubstituted or substituted with at least one R 10a and at least one other of R 11 to R 15 is a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , c2
OLEDs integrated with touch screens · CPC title
comprising colour filters or colour changing media [CCM] · CPC title
Connection of the pixel electrodes to the thin film transistors [TFT] · CPC title
Encapsulations · CPC title
comprising dopants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.